Financing drug discovery for orphan diseases
Recently proposed 'megafund' financing methods for funding translational medicine and drug development require billions of dollars in capital per megafund to de-risk the drug discovery process enough to issue long-term bonds. Here, we demonstrate that the same financing methods can be appl...
Full description
Bibliographic Details
| Main Authors: |
Gromatzky, Austin A.
(Contributor),
Stein, Roger Mark
(Contributor),
Fernandez, Jose-Maria
(Contributor),
Fagnan, David E.
(Author),
Lo, Andrew W
(Author) |
|---|
| Other Authors: |
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
(Contributor),
Massachusetts Institute of Technology. Department of Biology
(Contributor),
Massachusetts Institute of Technology. Operations Research Center
(Contributor),
Sloan School of Management
(Contributor),
Sloan School of Management. Laboratory for Financial Engineering
(Contributor),
Fagnan, David Erik
(Contributor),
Lo, Andrew W.
(Contributor) |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Elsevier B.V.,
2014-10-09T16:58:33Z.
|
|---|
| Subjects: | |
|---|
| Online Access: | Get fulltext
|
|---|
